Amebic liver abscess by Entamoeba histolytica.

Area of Science:

• Infectious Diseases
• Hepatology
• Parasitology

Background:

• Amebic liver abscesses (ALAs) are the most common extraintestinal manifestation of invasive amebiasis caused by Entamoeba histolytica.
• ALAs complicate 9% of amebiasis cases and caused approximately 50,000 deaths globally in 2010, remaining a public health issue in endemic regions.
• Entamoeba histolytica invades the intestinal mucosa, with trophozoites entering circulation and forming abscesses in the liver.

Purpose of the Study:

• To review the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of amebic liver abscesses.
• To highlight the importance of accurate diagnostic methods for Entamoeba histolytica infections.
• To emphasize the efficacy of medical management for ALAs.

Main Methods:

• Literature review of amebic liver abscesses.
• Analysis of diagnostic approaches including imaging, antibody detection, PCR, and ELISA.
• Evaluation of treatment strategies involving amebicidal and luminal cysticidal agents.

Main Results:

• Clinical presentation may mimic colitis, with symptoms including upper-right abdominal pain and fever.
• Diagnosis relies on non-specific liver imaging and serological tests, but distinguishing acute from past infections is challenging.
• PCR and ELISA are primary diagnostic tools for detecting Entamoeba histolytica.

Conclusions:

• ALAs are treatable with amebicidal drugs, with percutaneous drainage needed in only about 15% of cases.
• Prognosis for ALAs is generally good, with high rates of recovery.
• Further research is needed to establish the most efficacious diagnostic methods for ALAs.